Stroke

September 23, 2017

Natural product-derived therapy for Stroke: Catalpol, isolated from Catalpa, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 23/June/2017, 11.01 pm

Natural product-derived therapy for Stroke: Catalpol, isolated from Catalpa, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 23/June/2017, 11.01 pm https://genomediscovery.org/wp-content/uploads/2017/09/Catalpol-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/09/Catalpol-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT1.jpg September 23, 2017 September 23, 2017

Introduction: What they say A recent study from Research Center for Neurobiology and Department of Neurobiology, Xuzhou Medical College, 209 Tongshan Road, Xuzhou, Jiangsu 221004, PR China; and School of Public…

September 8, 2017

Natural product-derived therapy for Stroke: β-Cryptoxanthin, Sweet peppers, among others, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 9/September/2017, 1.01 am

Natural product-derived therapy for Stroke: β-Cryptoxanthin, Sweet peppers, among others, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 9/September/2017, 1.01 am https://genomediscovery.org/wp-content/uploads/2017/09/β-Cryptoxanthin-increases-BDNF-and-NAMPT-and-attenuate-stroke.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/09/β-Cryptoxanthin-increases-BDNF-and-NAMPT-and-attenuate-stroke.jpg September 8, 2017 September 8, 2017

September 7, 2017

Molecular therapy for Stroke: Dehydroepiandrosterone (DHEA) attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 8/September/2017, 12.39 am

Molecular therapy for Stroke: Dehydroepiandrosterone (DHEA) attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 8/September/2017, 12.39 am https://genomediscovery.org/wp-content/uploads/2017/09/DHEA-induces-BDNF-and-NAMPT-expression-increases-learning-and-memory-and-attenuates-neuronal-apoptosis-and-stroke.jpg1_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/09/DHEA-induces-BDNF-and-NAMPT-expression-increases-learning-and-memory-and-attenuates-neuronal-apoptosis-and-stroke.jpg1_.jpg September 7, 2017 September 7, 2017

September 4, 2017

Molecular therapy for Stroke: Ruxolitinib (brand name: Jakavi), a drug used in the treatment of Myelofibrosis, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 5/September/2017, 3.34 am

Molecular therapy for Stroke: Ruxolitinib (brand name: Jakavi), a drug used in the treatment of Myelofibrosis, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 5/September/2017, 3.34 am https://genomediscovery.org/wp-content/uploads/2017/09/Ruxolitinib-indues-BDNF-and-NAMPT-and-attenuates-stroke-1.jpg1_-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/09/Ruxolitinib-indues-BDNF-and-NAMPT-and-attenuates-stroke-1.jpg1_-1.jpg September 4, 2017 September 4, 2017

August 28, 2017

Molecular therapy for Stroke: The anticoagulant drug rivaroxaban (Xarelto) attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 28/August/2017, 11.38 pm

Molecular therapy for Stroke: The anticoagulant drug rivaroxaban (Xarelto) attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 28/August/2017, 11.38 pm https://genomediscovery.org/wp-content/uploads/2017/08/Rivaroxaban-increases-BDNF-and-NAMPT-expression-and-attenuates-stroke-jpg.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/08/Rivaroxaban-increases-BDNF-and-NAMPT-expression-and-attenuates-stroke-jpg.jpg August 28, 2017 August 28, 2017

August 14, 2017

Natural product-derived therapy for Stroke: Geniposide, isolated from Gardenia, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 14/August/2017, 11.42 pm

Natural product-derived therapy for Stroke: Geniposide, isolated from Gardenia, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 14/August/2017, 11.42 pm https://genomediscovery.org/wp-content/uploads/2017/08/Geniposide-increases-BDNF-and-NAMPT-expression-and-attenuates-stroke.jpg1_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/08/Geniposide-increases-BDNF-and-NAMPT-expression-and-attenuates-stroke.jpg1_.jpg August 14, 2017 August 14, 2017

Molecular therapy for Stroke: Dehydroepiandrosterone (DHEA) attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 8/September/2017, 12.39 am

Popular Post